WI

WT Investment Advisors Fund

North America, Wisconsin, United States, Oshkosh

Description

WT Investment Advisors Fund is a privately held American biotechnology companies.

Investor Profile

WT Investment Advisors Fund has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Private Equity, Series E, Series D rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Private Equity (33%)
  • Series E (33%)
  • Series D (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does WT Investment Advisors Fund frequently co-invest with?

Credit Suisse
North America, North Carolina, United States, Morrisville
Co-Investments: 1
TPG-Axon Capital
North America, New York, United States, New York
Co-Investments: 2
CV
North America, Utah, United States, Salt Lake City
Co-Investments: 1
Unilever Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Jennison Associates
North America, New York, United States, New York
Co-Investments: 2
SD
North America, Utah, United States, Salt Lake City
Co-Investments: 2

What are some of recent deals done by WT Investment Advisors Fund?

Merrimack

Cambridge, Massachusetts, United States

Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.

BiotechnologyHealth CarePharmaceutical
Private EquityApr 14, 2011
Amount Raised: $77,000,000
Merrimack

Cambridge, Massachusetts, United States

Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.

BiotechnologyHealth CarePharmaceutical
Series EApr 3, 2006
Amount Raised: $65,000,000
Merrimack

Cambridge, Massachusetts, United States

Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.

BiotechnologyHealth CarePharmaceutical
Series DApr 20, 2005
Amount Raised: $28,300,000